Simple and reproducible ELISA for C-Reactive protein

Clinical Chemistry

Volumn 55, Issue 2, 2009, Pages 376-377

  Tracy, Russell P ^a  

^a UNIVERSITY OF VERMONT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; ALBUMIN; BIOLOGICAL MARKER; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8 CONCENTRATE; C REACTIVE PROTEIN; CHOLESTEROL; FIBRINOGEN;

ACUTE HEART INFARCTION; ALBUMIN BLOOD LEVEL; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INFLAMMATION; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NOTE; PROTEIN BLOOD LEVEL; REPRODUCIBILITY;

EID: 59649102732     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2008.105403     Document Type: Note

References (6)

1. Pepys M. C-reactive protein fifty years on. Lancet 1981:653-6.
2. Fraser C, Harris E. Generation and application of data on biological variation in clinical chemistry. Crit Rev Clin Lab Sci 1989;27:409-37.
3. Ridker P, Cushman M, Stampfer M, Tracy R, Hennekens C. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-9.
4. Tracy R, Lemaitre R, Psaty B, Ives D, Evans R, Cushman M, et al. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly: results from the Cardiovascular Health Study and the Rural Health Promotion Project Arterioscler Thromb Vasc Biol 1997;17:1121-7.
5. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003;107:499-511.
6. Rifai N, Tracy RP, Ridker PM. Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin Chem 1999;45:2136-41.